SCHEMBL9849181

SCHEMBL9849181

NCCc1cccc(CO[PH](=O)OCc2cccc(CCN)c2)c1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 8/20 0.53
DRD2 P14416 1/20 0.53
DRD1 P21728 1/20 0.53
HTR6 P50406 2/20 0.45
MAOB P27338 4/20 0.44
CYP2A6 P11509 1/20 0.43
HTR2A P28223 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LOXL2 Q9Y4K0 1/20 0.43
HTR2C P28335 1/20 0.43
ACHE P22303 1/20 0.43
NOS1 P29475 2/20 0.42
CYP2D6 P10635 1/20 0.42
NOS3 P29474 1/20 0.42
NOS2 P35228 1/20 0.42
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9849186 0.86 TAAR1 (0.55) TAAR1DRD2DRD1HTR6MAOB
SCHEMBL9849123 0.80 TAAR1 (0.52) TAAR1MAOBCYP2A6HTR2ASMN1; SMN2
SCHEMBL659100 0.79 TAAR1 (0.70) TAAR1DRD2DRD1HTR6CYP2A6
SCHEMBL6257617 0.79 CYP19A1 (0.50) MAOBACHE
SCHEMBL9849210 0.79 TRPA1 (0.38) MAOBNOS1CYP2D6NOS3NOS2
Hydrochloric Acid SCHEMBL3957562 0.77 TAAR1 (0.67) TAAR1DRD2DRD1HTR6MAOB
SCHEMBL1046364 0.77 TAAR1 (0.61) TAAR1DRD2DRD1HTR6MAOB
SCHEMBL29149473 0.76 IDO1 (0.58) TAAR1MAOB
SCHEMBL27264275 0.76 IDO1 (0.58) TAAR1MAOB
SCHEMBL27370549 0.76 IDO1 (0.58) TAAR1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0421436-A2 Substituted carboxytetrahydroisoquinolines and derivatives thereof having pharmaceutical activity WARNER-LAMBERT COMPANY (US) 1991-04-10 EP claimed
EP-0421436-A2 Substituted carboxytetrahydroisoquinolines and derivatives thereof having pharmaceutical activity WARNER-LAMBERT COMPANY (US) 1991-04-10 EP disclosed